Today's Date: March 19, 2024
Wyndham's Women Own the Room Initiative Drives Over One Dozen Hotel Openings   •   Sprouts Farmers Market Announces New NIL Deals   •   LINCOLN MEMORIAL EASTER SUNRISE SERVICE IS MARCH 31: A WASHINGTON TRADITION FOR 44 YEARS   •   Republic of Zambia to Become First Nation to Join Operation HOPE's 'Financial Literacy for All' Initiative   •   Waldo International School Celebrates Women's History Month with Inspirational Speakers   •   NEW BOOK ENERGIZES MID-CAREER WOMEN BY PROMOTING INTENTIONAL SELF-ADVOCACY AND REJECTING SOCIETAL NORMS THAT HOLD WOMEN BACK   •   Northwest Harvest Announces Partnership with Network of Giving   •   Core & Main Announces Fiscal 2023 Fourth Quarter and Full-Year Results   •   Illuminating Widespread Bias in Education Leadership: Women Leading Ed Releases First-Ever Survey of Women Leaders from Across t   •   Trnd Launches Advanced Brand Analytics   •   Best Life Insurance Plans for Women - Our Top Picks for 2024   •   Owens Corning Publishes 2023 Sustainability Report   •   Varsity Tutors Rolls Out 2024 Summer Learning Programming   •   EA SPORTS FC™ Announce New Sponsorship of UEFA’s Women in Football Leadership Programme   •   Jilly Bing Launches First True-to-Life Asian American Doll at Toys"R"Us at Macy's   •   Turning Clutter into Cash: Nextdoor Insights Reveal an Upcycling Opportunity in America’s Annual Spring Cleaning Trend   •   Viridi Energy Acquires Maine Digester Facility for Industry-Leading Biosolids-to-RNG Project   •   Spiritus Announces the First “Carbon Orchard” for Direct Air Capture, will Sequester 2 Megatons of Carbon Annually i   •   ProLogium Showcases Path to De-carbonization with Its Exclusive Solid-State Battery at Taipei Net Zero City Expo   •   101 Mobility Celebrates Excellence with Inaugural Franchise of the Year Award at Annual Conference in Nashville, TN
Bookmark and Share

Scenic Biotech Enters Cooperative Research & Development Agreement with the National Institutes of Health for Genetic Modifi

AMSTERDAM , February 01 /Businesswire/ - Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to support its therapeutic program for the treatment of Niemann-Pick Type C (NPC) disease, which is a severe, progressive and lethal neurological disorder. The goal of the collaboration is to obtain clinical insights into genes that can reduce the severity of NPC. Under the terms of the CRADA, NICHD will grant Scenic Biotech access to its extensive clinical dataset and whole genome DNA sequence data derived from NPC patients. Forbes D. Porter, MD, PhD, Senior Investigator at NICHD, will be the principal investigator for this study based on his long-running clinical protocols that track the natural history of rare genetic disorders, including NPC.

“The CRADA with the NIH will help advance our work toward identifying genetic modifiers for NPC. Our aim is to develop novel therapeutics that act by suppressing or completely blocking the effect of a disease-causing mutated gene. Through the combined efforts with Dr. Porter’s team, we hope to further enable the discovery of a tailor-made, disease-modifying small molecule therapeutic for this devastating disease,” commented Sebastian Nijman, CSO and co-founder of Scenic Biotech.

About Scenic Biotech

Scenic Biotech is at the forefront of identifying genetic modifiers, naturally occurring genes that compensate for mutations responsible for severe diseases. Our robust technologies, reproducible approach and high-resolution insights into disease pathways enable us to develop small-molecule compounds that start with genetic modifiers to provide new therapeutic concepts. By understanding the genome’s power to correct toward health, Scenic Biotech will bring novel therapeutics to patients in need.


STORY TAGS: Managed Care, Research, Pharmaceutical, Infectious Diseases, Hospitals, Genetics, Clinical Trials, Science, Biotechnology, Nursing, Alternative Medicine, Health, Other Science, Contract/Agreement, Product/Service, Netherlands, Europe,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News